Stay updated on CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Sign up to get notified when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.

Latest updates to the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 has been added to the Study Record Versions, and Revision: v3.4.3 has been removed. This updates the study record version history on the page.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new minor revision entry (v3.4.2) was added, and a funding-status notice as well as the older revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check43 days agoChange DetectedThe history shows an administrative funding notice and a new revision tag (v3.4.1) for the record. These changes are metadata and do not alter the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check50 days agoChange DetectedThe Record History page now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with a revision label showing v3.4.0. 'No FEAR Act Data' was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the Record History, reflecting metadata updates rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.